| Patent Number |
Title Of Patent |
Date Issued |
| 6689755 |
Method of stabilizing biologically active substances |
February 10, 2004 |
| The present invention relates to a rapid and readily reproducible process for stabilizing biologically active substances by combining the biologically active substance witha a stabilizingmixture and drying the resulting mixture into a dry, amorphous product by means of convection dry |
| 6664284 |
Stabilized carvedilol injection solution |
December 16, 2003 |
| Ready-to-use, aqueous injection solutions containing carvedilol (1-(9H-carbazolyl-4-yloxy)-3-[[(2-(2-methoxyphenoxy)ethyl]-amino]-2-propan ol) or its pharmacologically harmless salts which are stable in storage and are well tolerated by veins are disclosed. |
| 6627221 |
Pharmaceutical composition containing diphosphonic acid or salt thereof |
September 30, 2003 |
| The invention relates to a solid pharmaceutical form of administration containing a diphosphonic acid or a physiologically compatible salt thereof as the active substance, wherein the active substance is present in granulate form, optionally together with pharmaceutical adjuvants in |
| 6521262 |
Solid instant-release forms of administration and process for producing the same |
February 18, 2003 |
| The present invention concerns solid instant-release forms of administration (IR form of administration) comprising therapeutic active substances or active substance concentrates in particular lipid conjugates of nucleosides which have gel-forming properties in aqueous media as well |
| 6419955 |
Process for making bisphosphonate compositions |
July 16, 2002 |
| The present invention relates to a process for the preparation of bisphonate-containing pharmaceutical compositions for oral administration wherein the active substance is wet-granulated in a fluidized-bed granulator and the wet granulate is dried in the fluidised bed granulator. The |
| 6303113 |
Process for the production of pharmaceutical preparations containing human protein for infusion |
October 16, 2001 |
| The present invention concerns a process for the production of well-tolerated, preserved injection or infusion solutions containing human protein. |
| 6294196 |
Pharmaceutical composition containing diphosphonic acid or salt thereof |
September 25, 2001 |
| The invention relates to a solid pharmaceutical form of administration containing a diphosphonic acid or a physiologically compatible salt thereof as the active substance, wherein the active substance is present in granulate form, optionally together with pharmaceutical adjuvants in |
| 6143326 |
Oral pharmaceutical preparation containing ibandronat |
November 7, 2000 |
| The invention is directed to well-tolerated pharmaceutical compositions for oral application, containing ibandronate or a physiologically tolerable salt thereof as active substance, the administration form consisting of an active substance-containing inner portion enclosed in such fashio |
| 5919757 |
Aqueous pharmaceutical preparations of G-CSF with a long shelf life |
July 6, 1999 |
| Aqueous pharmaceutical preparations of G-CSF are disclosed that are stable on storage and a buffer selected from the group consisting of a salt of citrate, maleate, a combination of phosphate and citrate, and arginine; and at least one surfactant. |
| 5919443 |
Stable lyophilized pharmaceutical preparations of G-CSF |
July 6, 1999 |
| The present invention concerns lyophilized pharmaceutical preparations of G-CSF that contain maltose, raffinose, sucrose, trehalose or amino sugar as stabilizing agents. In additon the invention concerns a process for the production of stabilized lyophilisates as well as the use of malto |
| 5747030 |
Pharmaceutical preparation containing plasminogen activators |
May 5, 1998 |
| The invention relates to pharmaceutical preparations containing plasminogen activators, sugars and tranexamic acid, in the form of a lyophilisate or an injection or infusion solution. In particular, the preparations contain a sugar, phosphate buffer, tranexamic acid as well as a surfacta |
| 5662918 |
Pharmaceutical agents containing diphosphonic acids and salts thereof |
September 2, 1997 |
| The invention concerns pharmaceutical preparations that are stable on storage, which contain at least one diphosphonic acid and/or at least one physiologically acceptable salt of such an acid as the active substance. |
| 5504099 |
Injection solutions of azosemide which are ready for injection |
April 2, 1996 |
| Aqueous injection solution that is ready-for-injection of a water-soluble, physiologically well-tolerated azosemide salt of an organic amide, which contains an organic solvent and if desired, a physiologically well-tolerated buffer and it concerns a process for the production of such |
| 5503827 |
Process for the production of multi-dose pharmaceutical preparations containing isolated or reco |
April 2, 1996 |
| The present invention concerns a process for the production of well-tolerated, preserved injection or infusion solutions containing human protein. |
| 5324749 |
Pharmaceutical aqueous solution of 4-[2-(benzene-sulphonylamino)-ethyl]-phenoxyacetic acid |
June 28, 1994 |
| The present invention concerns a storage-stable, aqueous solution of 4-[2-(benzenesulphonylamino)-ethyl]-phenoxyacetic acid for pharmaceutical purposes. |
| 4992419 |
Stabilized erythropoietin preparations |
February 12, 1991 |
| A compatible, storage-stable human protein preparation containing a human protein, a physiologically compatible buffer and optionally complex formers, isotonia-adjusting agents, calcium chloride and other materials usual for injection purposes which, in an injectable form, contains 5 to |
| 4861786 |
Composition for a stable vein compatible injectable solution of torasemide process for the prepa |
August 29, 1989 |
| The present invention provides an aqueous, alkaline injection solution of torasemide ready for injection, which contains a physiologically compatible alkaline buffer with a pH value of from 9.3 to 9.9 and with a buffer capacity of up to 0.1 val/liter together with an organic solvent in |
| 4191772 |
Instillation composition |
March 4, 1980 |
| An instillation composition, comprising an effective amount of at least one sparingly soluble active material suspended or partly dissolved in an aqueous emulsion containing a swelling agent. Advantageously the active substance is nitrofurantoin or a quinolone or pyridazine derivative, t |
